Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France

BackgroundFew studies have estimated Chlamydia trachomatis (CT) prevalence in the general population, most prevalence studies being based on people already attending healthcare settings.ObjectivesTo estimate the prevalence of CT in France, assess the feasibility of home sampling without any face-to-...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sexually transmitted infections Ročník 86; číslo 4; s. 263 - 270
Hlavní autoři: Goulet, V, de Barbeyrac, B, Raherison, S, Prudhomme, M, Semaille, C, Warszawski, J
Médium: Journal Article
Jazyk:angličtina
Vydáno: London BMJ Publishing Group Ltd 01.08.2010
BMJ Publishing Group
BMJ Publishing Group LTD
Témata:
ISSN:1368-4973, 1472-3263, 1472-3263
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract BackgroundFew studies have estimated Chlamydia trachomatis (CT) prevalence in the general population, most prevalence studies being based on people already attending healthcare settings.ObjectivesTo estimate the prevalence of CT in France, assess the feasibility of home sampling without any face-to-face intervention and identify risk factors associated with CT infection using data from the Contexte de la Sexualité (CSF) survey on sexual behaviour; a national population-based survey, carried out by telephone in 2006.MethodsA random subsample of sexually experienced people aged 18–44 (N=4957) were invited to participate in a CT home-sampling study (NatChla study). Participants' samples were tested for CT by PCR. Percentages were weighted for unequal selection probabilities and post-stratified based on French population census data. Independent risk factors were identified by logistic regression.ResultsCT prevalence in people aged 18–44 was estimated at 1.4% (95% CI 0.8% to 2.6%) for men, and 1.6% (95% CI 1.0% to 2.5%) for women. Increased rates were found in subjects aged 18–29: 2.5% (95% CI 1.2% to 5.0%) for men and 3.2% (95% CI 2.0% to 5.3%) for women. CT infection was associated, for both genders, with having their last sexual intercourse with a casual partner. Other risk factors were for men, having last intercourse with a new partner, living in the Paris area, and for women, multiple partners during the previous year, same sex partners and a low level of education.ConclusionsCT prevalence in France is similar to that in other developed countries. Home sampling proved feasible and useful to reach members of the population with limited access to traditional care.
AbstractList Few studies have estimated Chlamydia trachomatis (CT) prevalence in the general population, most prevalence studies being based on people already attending healthcare settings. To estimate the prevalence of CT in France, assess the feasibility of home sampling without any face-to-face intervention and identify risk factors associated with CT infection using data from the Contexte de la Sexualité (CSF) survey on sexual behaviour; a national population-based survey, carried out by telephone in 2006. A random subsample of sexually experienced people aged 18-44 (N=4957) were invited to participate in a CT home-sampling study (NatChla study). Participants' samples were tested for CT by PCR. Percentages were weighted for unequal selection probabilities and post-stratified based on French population census data. Independent risk factors were identified by logistic regression. CT prevalence in people aged 18-44 was estimated at 1.4% (95% CI 0.8% to 2.6%) for men, and 1.6% (95% CI 1.0% to 2.5%) for women. Increased rates were found in subjects aged 18-29: 2.5% (95% CI 1.2% to 5.0%) for men and 3.2% (95% CI 2.0% to 5.3%) for women. CT infection was associated, for both genders, with having their last sexual intercourse with a casual partner. Other risk factors were for men, having last intercourse with a new partner, living in the Paris area, and for women, multiple partners during the previous year, same sex partners and a low level of education. CT prevalence in France is similar to that in other developed countries. Home sampling proved feasible and useful to reach members of the population with limited access to traditional care.
Background Few studies have estimated Chlamydia trachomatis (CT) prevalence in the general population, most prevalence studies being based on people already attending healthcare settings. Objectives To estimate the prevalence of CT in France, assess the feasibility of home sampling without any face-to-face intervention and identify risk factors associated with CT infection using data from the Contexte de la Sexualité (CSF) survey on sexual behaviour; a national population-based survey, carried out by telephone in 2006. Methods A random subsample of sexually experienced people aged 18-44 (N=4957) were invited to participate in a CT home-sampling study (NatChla study). Participants' samples were tested for CT by PCR. Percentages were weighted for unequal selection probabilities and post-stratified based on French population census data. Independent risk factors were identified by logistic regression. Results CT prevalence in people aged 18-44 was estimated at 1.4% (95% CI 0.8% to 2.6%) for men, and 1.6% (95% CI 1.0% to 2.5%) for women. Increased rates were found in subjects aged 18-29: 2.5% (95% CI 1.2% to 5.0%) for men and 3.2% (95% CI 2.0% to 5.3%) for women. CT infection was associated, for both genders, with having their last sexual intercourse with a casual partner. Other risk factors were for men, having last intercourse with a new partner, living in the Paris area, and for women, multiple partners during the previous year, same sex partners and a low level of education. Conclusions CT prevalence in France is similar to that in other developed countries. Home sampling proved feasible and useful to reach members of the population with limited access to traditional care.
Few studies have estimated Chlamydia trachomatis (CT) prevalence in the general population, most prevalence studies being based on people already attending healthcare settings.BACKGROUNDFew studies have estimated Chlamydia trachomatis (CT) prevalence in the general population, most prevalence studies being based on people already attending healthcare settings.To estimate the prevalence of CT in France, assess the feasibility of home sampling without any face-to-face intervention and identify risk factors associated with CT infection using data from the Contexte de la Sexualité (CSF) survey on sexual behaviour; a national population-based survey, carried out by telephone in 2006.OBJECTIVESTo estimate the prevalence of CT in France, assess the feasibility of home sampling without any face-to-face intervention and identify risk factors associated with CT infection using data from the Contexte de la Sexualité (CSF) survey on sexual behaviour; a national population-based survey, carried out by telephone in 2006.A random subsample of sexually experienced people aged 18-44 (N=4957) were invited to participate in a CT home-sampling study (NatChla study). Participants' samples were tested for CT by PCR. Percentages were weighted for unequal selection probabilities and post-stratified based on French population census data. Independent risk factors were identified by logistic regression.METHODSA random subsample of sexually experienced people aged 18-44 (N=4957) were invited to participate in a CT home-sampling study (NatChla study). Participants' samples were tested for CT by PCR. Percentages were weighted for unequal selection probabilities and post-stratified based on French population census data. Independent risk factors were identified by logistic regression.CT prevalence in people aged 18-44 was estimated at 1.4% (95% CI 0.8% to 2.6%) for men, and 1.6% (95% CI 1.0% to 2.5%) for women. Increased rates were found in subjects aged 18-29: 2.5% (95% CI 1.2% to 5.0%) for men and 3.2% (95% CI 2.0% to 5.3%) for women. CT infection was associated, for both genders, with having their last sexual intercourse with a casual partner. Other risk factors were for men, having last intercourse with a new partner, living in the Paris area, and for women, multiple partners during the previous year, same sex partners and a low level of education.RESULTSCT prevalence in people aged 18-44 was estimated at 1.4% (95% CI 0.8% to 2.6%) for men, and 1.6% (95% CI 1.0% to 2.5%) for women. Increased rates were found in subjects aged 18-29: 2.5% (95% CI 1.2% to 5.0%) for men and 3.2% (95% CI 2.0% to 5.3%) for women. CT infection was associated, for both genders, with having their last sexual intercourse with a casual partner. Other risk factors were for men, having last intercourse with a new partner, living in the Paris area, and for women, multiple partners during the previous year, same sex partners and a low level of education.CT prevalence in France is similar to that in other developed countries. Home sampling proved feasible and useful to reach members of the population with limited access to traditional care.CONCLUSIONSCT prevalence in France is similar to that in other developed countries. Home sampling proved feasible and useful to reach members of the population with limited access to traditional care.
Objectives: Few studies have estimated Chlamydia trachomatis (CT) prevalence in the general population, most prevalence studies being based on people already attending healthcare settings. We estimated the prevalence of CT in France, assessed the feasibility of home sampling without any face-to-face intervention, and identified risk factors associated with CT infection using data from the Contexte de la Sexualité (CSF) survey on sexual behaviour. Methods: CSF was a national population-based survey, carried out by telephone in 2006. A random subsample of sexually experienced individuals aged 18-44 (N=4957) were invited to participate in a CT home-sampling study (NatChla Study). Participants were tested for CT by PCR. Percentages were weighted for unequal selection probabilities and post-stratified based on French population census data. Independent risk factors were identified by logistic regression. Results: CT prevalence in individuals aged 18-44 was estimated at 1.4 % [95 % CI: 0.8- 2.6] for men, and 1.6 % [95%CI:1.0- 2.5] for women. We observed increased rates in individuals aged 18-29: 2.5 % [95%CI:1.2-5.0] for men and 3.2 % [95%CI:2.0 -5.3] for women. CT infection was associated, for both genders, with having their last sexual intercourse with a casual or new partner. Other risk factors were for men, living in the Paris area, and for women, multiple partners during the previous year, same sex partners and a low level of education. Conclusions: CT prevalence in France is similar to other developed countries. Home-sampling proved feasible and useful to reach members of the population with limited access to traditional care.
BackgroundFew studies have estimated Chlamydia trachomatis (CT) prevalence in the general population, most prevalence studies being based on people already attending healthcare settings.ObjectivesTo estimate the prevalence of CT in France, assess the feasibility of home sampling without any face-to-face intervention and identify risk factors associated with CT infection using data from the Contexte de la Sexualité (CSF) survey on sexual behaviour; a national population-based survey, carried out by telephone in 2006.MethodsA random subsample of sexually experienced people aged 18–44 (N=4957) were invited to participate in a CT home-sampling study (NatChla study). Participants' samples were tested for CT by PCR. Percentages were weighted for unequal selection probabilities and post-stratified based on French population census data. Independent risk factors were identified by logistic regression.ResultsCT prevalence in people aged 18–44 was estimated at 1.4% (95% CI 0.8% to 2.6%) for men, and 1.6% (95% CI 1.0% to 2.5%) for women. Increased rates were found in subjects aged 18–29: 2.5% (95% CI 1.2% to 5.0%) for men and 3.2% (95% CI 2.0% to 5.3%) for women. CT infection was associated, for both genders, with having their last sexual intercourse with a casual partner. Other risk factors were for men, having last intercourse with a new partner, living in the Paris area, and for women, multiple partners during the previous year, same sex partners and a low level of education.ConclusionsCT prevalence in France is similar to that in other developed countries. Home sampling proved feasible and useful to reach members of the population with limited access to traditional care.
Author Prudhomme, M
Warszawski, J
Goulet, V
Semaille, C
de Barbeyrac, B
Raherison, S
Author_xml – sequence: 1
  givenname: V
  surname: Goulet
  fullname: Goulet, V
  email: v.goulet@invs.sante.fr
  organization: Institut de Veille Sanitaire, Saint-Maurice, France
– sequence: 2
  givenname: B
  surname: de Barbeyrac
  fullname: de Barbeyrac, B
  email: v.goulet@invs.sante.fr
  organization: National Reference Centre for Chlamydia, University of Bordeaux , Bordeaux, France
– sequence: 3
  givenname: S
  surname: Raherison
  fullname: Raherison, S
  email: v.goulet@invs.sante.fr
  organization: National Reference Centre for Chlamydia, University of Bordeaux , Bordeaux, France
– sequence: 4
  givenname: M
  surname: Prudhomme
  fullname: Prudhomme, M
  email: v.goulet@invs.sante.fr
  organization: Conseil Général, Saint-Denis, France
– sequence: 5
  givenname: C
  surname: Semaille
  fullname: Semaille, C
  email: v.goulet@invs.sante.fr
  organization: Institut de Veille Sanitaire, Saint-Maurice, France
– sequence: 6
  givenname: J
  surname: Warszawski
  fullname: Warszawski, J
  email: v.goulet@invs.sante.fr
  organization: University Paris-Sud, UMRS , Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, F- France
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23092468$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20660590$$D View this record in MEDLINE/PubMed
https://hal.science/hal-00557458$$DView record in HAL
BookMark eNqFkUuP0zAUhSM0iHnAmh2yhBACKR2_7bAbdSiDqIAFIMTGchxbdXGSYifV9N_jTkqRZgErv75z7vU958VJ13e2KJ4iOEOI8Ms0-BmGsJpBIgXDD4ozRAUuCebkJO8JlyWtBDktzlNaQwi5YNWj4hRDziGr4FnhPke71cF2xoLegfkq6HbXeA2GqM2qb_Xg0xsQbRrDkICLfQuGlQXOxzSALr_2nQ5g02_GcHcoa51sA9IYt3YHfAcWUWfvx8VDp0OyTw7rRfF18fbL_KZcfnr3fn61LGsG8VC63JSkjFNpHK-ZpRbVNYHGMeMqg6TmljnspHa4YU3DaCUdJ0LLGlnqhCEXxavJd6WD2kTf6rhTvfbq5mqp9ncQMiYok1uU2ZcTu4n9r9GmQbU-GRuC7mw_JiVoBTFhFcnk83vkuh9j_nhSSEgkMOdYZurZgRrr1jbH8n-GnYEXB0Ano4PbT8anvxyBFaZ8b3Q5cSb2KUXrjgiCah-7yrGrfexqij0r2D2F8cNdHjlGH_6hKyedT4O9PZbR8afiggimPn6bq-sfi8UH-Z0qnvnXE1-36_829RsRZMz6
CitedBy_id crossref_primary_10_1258_ijsa_2010_010354
crossref_primary_10_1016_S0140_6736_13_61947_9
crossref_primary_10_1371_journal_pone_0115753
crossref_primary_10_1097_GCO_0b013e32834ac776
crossref_primary_10_1186_1471_2458_13_189
crossref_primary_10_1186_s13063_017_2211_1
crossref_primary_10_2217_fmb_13_3
crossref_primary_10_1371_journal_pone_0089658
crossref_primary_10_1136_bmjopen_2015_007691
crossref_primary_10_1155_2014_183167
crossref_primary_10_1016_j_forsciint_2024_112070
crossref_primary_10_1186_s12879_020_05307_w
crossref_primary_10_1371_journal_pone_0104943
crossref_primary_10_1097_OLQ_0000000000000351
crossref_primary_10_1186_s12905_017_0428_5
crossref_primary_10_1016_j_gofs_2019_03_007
crossref_primary_10_1136_sextrans_2015_052511
crossref_primary_10_5812_jjm_8_4_2015_15576
crossref_primary_10_1016_j_lpm_2012_09_022
crossref_primary_10_1136_sextrans_2015_052510
crossref_primary_10_1016_j_jgyn_2012_09_015
crossref_primary_10_1016_j_jgyn_2012_09_016
crossref_primary_10_1016_S1773_035X_21_00067_8
crossref_primary_10_1093_trstmh_trv014
crossref_primary_10_1016_j_lpm_2012_09_025
crossref_primary_10_1371_journal_pone_0196516
crossref_primary_10_1016_j_annder_2016_05_013
crossref_primary_10_1186_s12879_018_3595_6
crossref_primary_10_1186_1471_2334_13_534
crossref_primary_10_1016_j_gyobfe_2014_05_015
crossref_primary_10_1186_1471_2334_12_319
crossref_primary_10_1186_s12879_018_3382_4
crossref_primary_10_1186_s12879_020_05066_8
crossref_primary_10_3390_biomedicines12091999
crossref_primary_10_1136_sextrans_2011_050223
crossref_primary_10_1186_1471_2334_14_223
crossref_primary_10_1097_OLQ_0b013e3182383097
crossref_primary_10_1016_j_forsciint_2016_04_031
crossref_primary_10_1258_ijsa_2011_010481
crossref_primary_10_5694_mja11_10745
crossref_primary_10_54044_RAMI_2023_02_05
crossref_primary_10_1016_j_amepre_2015_01_014
crossref_primary_10_1016_j_respe_2016_05_007
crossref_primary_10_1371_journal_pone_0195158
crossref_primary_10_1097_OLQ_0b013e31821597ca
crossref_primary_10_1371_journal_pone_0090174
crossref_primary_10_1186_1471_2334_13_388
crossref_primary_10_1016_j_diagmicrobio_2015_01_014
crossref_primary_10_1016_j_jadohealth_2016_03_006
crossref_primary_10_1186_s12889_015_2069_7
crossref_primary_10_1016_S0992_5945_10_70521_3
crossref_primary_10_1177_0956462414555930
crossref_primary_10_1186_s12879_021_06646_y
crossref_primary_10_1016_j_contraception_2012_04_012
crossref_primary_10_1002_rfc2_20
crossref_primary_10_1097_MD_0000000000014572
crossref_primary_10_4161_hv_36163
crossref_primary_10_1186_s12879_018_3432_y
crossref_primary_10_1186_1471_2458_14_1147
crossref_primary_10_2196_resprot_9797
crossref_primary_10_1080_00224499_2012_657264
crossref_primary_10_1016_j_puhip_2024_100554
crossref_primary_10_1177_09564624251361294
crossref_primary_10_3390_diagnostics12081795
crossref_primary_10_1007_s00404_011_2085_5
crossref_primary_10_1097_IPC_0000000000000514
crossref_primary_10_1097_OLQ_0b013e318254ca6f
crossref_primary_10_1177_0956462420947587
crossref_primary_10_1093_eurpub_ckae074
crossref_primary_10_1097_OLQ_0000000000000616
crossref_primary_10_1186_1471_2458_12_176
crossref_primary_10_1016_S1473_3099_17_30310_9
crossref_primary_10_1016_S1473_3099_22_00148_7
crossref_primary_10_1258_ijsa_2011_011194
crossref_primary_10_1371_journal_pone_0172561
crossref_primary_10_1136_sextrans_2020_054488
crossref_primary_10_1016_S1773_035X_11_70790_0
crossref_primary_10_1016_j_gofs_2021_01_003
crossref_primary_10_3389_fpubh_2022_1005334
crossref_primary_10_1016_j_bjid_2020_04_014
crossref_primary_10_1017_S0950268812002567
ContentType Journal Article
Contributor Andro, A
Ferrand, M
Levinson, Sh
Le Van, Ch
Bajos, Nathalie
Razafindratsima, N
Beltzer, N
Bozon, M
Goulet, V
Laporte, A
Toulemon, L
Leridon, H
Warszawski, J
Contributor_xml – sequence: 1
  givenname: Nathalie
  surname: Bajos
  fullname: Bajos, Nathalie
– sequence: 2
  givenname: M
  surname: Bozon
  fullname: Bozon, M
– sequence: 3
  givenname: N
  surname: Beltzer
  fullname: Beltzer, N
– sequence: 4
  givenname: A
  surname: Andro
  fullname: Andro, A
– sequence: 5
  givenname: M
  surname: Ferrand
  fullname: Ferrand, M
– sequence: 6
  givenname: V
  surname: Goulet
  fullname: Goulet, V
– sequence: 7
  givenname: A
  surname: Laporte
  fullname: Laporte, A
– sequence: 8
  givenname: Ch
  surname: Le Van
  fullname: Le Van, Ch
– sequence: 9
  givenname: H
  surname: Leridon
  fullname: Leridon, H
– sequence: 10
  givenname: Sh
  surname: Levinson
  fullname: Levinson, Sh
– sequence: 11
  givenname: N
  surname: Razafindratsima
  fullname: Razafindratsima, N
– sequence: 12
  givenname: L
  surname: Toulemon
  fullname: Toulemon, L
– sequence: 13
  givenname: J
  surname: Warszawski
  fullname: Warszawski, J
Copyright 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
2015 INIST-CNRS
Copyright: 2010 (c) 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
– notice: 2015 INIST-CNRS
– notice: Copyright: 2010 (c) 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
– notice: Distributed under a Creative Commons Attribution 4.0 International License
CorporateAuthor for the CSF group
CSF group
CorporateAuthor_xml – name: for the CSF group
– name: CSF group
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
88I
8AF
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
BTHHO
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
M0S
M1P
M2P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
Q9U
7X8
1XC
VOOES
DOI 10.1136/sti.2009.038752
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
BMJ Journals
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Science Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest Central Student

MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central Database Suite (ProQuest)
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Education
EISSN 1472-3263
EndPage 270
ExternalDocumentID oai:HAL:hal-00557458v1
4026576151
20660590
23092468
10_1136_sti_2009_038752
ark_67375_NVC_DZFFK8X4_6
sextrans
Genre Research Support, Non-U.S. Gov't
Multicenter Study
Journal Article
GeographicLocations France
Europe
GeographicLocations_xml – name: France
GroupedDBID ---
.GJ
.VT
08P
0R~
123
18M
2WC
354
39C
4.4
40O
53G
5RE
5VS
7X7
7~S
88E
88I
8AF
8FI
8FJ
8R4
8R5
AAHLL
AAKAS
AAOJX
AAWJN
AAWTL
AAYEP
ABAAH
ABJNI
ABKDF
ABMQD
ABOCM
ABUWG
ABVAJ
ACGFO
ACGFS
ACGOD
ACGTL
ACHTP
ACMFJ
ACOAB
ACOFX
ACQSR
ACTZY
ADBBV
ADCEG
ADFRT
ADZCM
AENEX
AFKRA
AFWFF
AGQPQ
AHMBA
AHNKE
AHQMW
AJYBZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZFZN
AZQEC
BAWUL
BENPR
BLJBA
BOMFT
BPHCQ
BTFSW
BTHHO
BVXVI
C45
CAG
CCPQU
COF
CS3
CXRWF
DIK
DU5
DWQXO
EBS
EJD
F5P
FEDTE
FYUFA
GNUQQ
H13
HAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
IAO
IEA
IHR
IOF
IPO
ITC
KQ8
L7B
M1P
M2P
N9A
NTWIH
NXWIF
O9-
OVD
P2P
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
R53
RHI
RMJ
RPM
RV8
TEORI
TR2
UAW
UKHRP
UYXKK
V24
VM9
W8F
YFH
YOC
YQY
ZXP
3V.
BSCLL
OK1
RHF
AAYXX
ACQHZ
AERUA
AFFHD
CITATION
PHGZM
PJZUB
PPXIY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
Q9U
7X8
1XC
VOOES
ID FETCH-LOGICAL-b502t-f059845648cf6b5e4e1bb30cf5cf9c18a6e5f2f8af2d5dd5498f637a8b1e4f7c3
IEDL.DBID M2P
ISICitedReferencesCount 89
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000280363600005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1368-4973
1472-3263
IngestDate Tue Oct 14 20:13:50 EDT 2025
Sun Nov 09 10:45:36 EST 2025
Tue Oct 07 07:02:10 EDT 2025
Thu Jan 02 22:29:39 EST 2025
Mon Jul 21 09:16:13 EDT 2025
Sat Nov 29 03:47:52 EST 2025
Tue Nov 18 22:32:51 EST 2025
Wed Oct 30 09:23:45 EDT 2024
Thu Apr 24 23:05:09 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Infection
Survey
Sexually transmitted disease
Prevalence
Chlamydiaceae
Chlamydiales
Bacteria
Chlamydia trachomatis
Epidemiology
Genital diseases
prevalence
population-based
Language English
License CC BY 4.0
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b502t-f059845648cf6b5e4e1bb30cf5cf9c18a6e5f2f8af2d5dd5498f637a8b1e4f7c3
Notes ArticleID:sextrans38752
istex:AA87CB43EAE5FEDB9349B30F741A0E614B05880E
local:sextrans;86/4/263
href:sextrans-86-263.pdf
ark:/67375/NVC-DZFFK8X4-6
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1451-3363
OpenAccessLink https://hal.science/hal-00557458
PMID 20660590
PQID 1781726628
PQPubID 2041053
PageCount 8
ParticipantIDs hal_primary_oai_HAL_hal_00557458v1
proquest_miscellaneous_749023593
proquest_journals_1781726628
pubmed_primary_20660590
pascalfrancis_primary_23092468
crossref_primary_10_1136_sti_2009_038752
crossref_citationtrail_10_1136_sti_2009_038752
istex_primary_ark_67375_NVC_DZFFK8X4_6
bmj_primary_10_1136_sti_2009_038752
PublicationCentury 2000
PublicationDate 2010-08-01
PublicationDateYYYYMMDD 2010-08-01
PublicationDate_xml – month: 08
  year: 2010
  text: 2010-08-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Sexually transmitted infections
PublicationTitleAlternate Sex Transm Infect
PublicationYear 2010
Publisher BMJ Publishing Group Ltd
BMJ Publishing Group
BMJ Publishing Group LTD
Publisher_xml – name: BMJ Publishing Group Ltd
– name: BMJ Publishing Group
– name: BMJ Publishing Group LTD
References Lippman, Jones, Luppi 2007; 34
Simms, Talebi, Rhia 2009; 36
Fenton, Korovessis, Johnson 2001; 358
Gaydos, Barnes, Aumakhan 2009; 36
Andersen, Olesen, Moller 2002; 185
Low 2007; 334
Adams, Charlett, Edmunds 2004; 80
van Bergen, Gotz, Richardus 2005; 81
Macleod, Salisbury, Low 2005; 33
Datta, Sternberg, Johnson 2007; 147
Paavonen, Eggert-Kruse 1999; 5
Herida, Michel, Goulet 2005; 35
Bajos, Bozon, Beltzer 2010; 24
Klavs, Rodrigues, Wellings 2004; 80
Lyytikainen, Kaasila, Hiltunen-Back 2008; 8
Verhoeven, Avonts, Meheus 2003; 79
Roberts, Robinson, Barton 2006; 82
Novak, Karlsson 2006; 82
Warszawski, Messiah, Lellouch 1997; 16
References_xml – volume: 80
  start-page: 354
  year: 2004
  article-title: Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies
  publication-title: Sex Transm Infect
– volume: 82
  start-page: 193
  year: 2006
  article-title: Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling
  publication-title: Sex Transm Infect
– volume: 8
  start-page: 169
  year: 2008
  article-title: A discrepancy of Chlamydia trachomatis incidence and prevalence trends in Finland 1983-2003
  publication-title: BMC Infect Dis
– volume: 35
  start-page: 281
  year: 2005
  article-title: (Epidemiology of sexually transmitted infections in France)
  publication-title: Med Mal Infect
– volume: 81
  start-page: 17
  year: 2005
  article-title: Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: results from the first national population based study in the Netherlands
  publication-title: Sex Transm Infect
– volume: 82
  start-page: 142
  year: 2006
  article-title: Simplifying chlamydia testing: an innovative Chlamydia trachomatis testing approach using the internet and a home sampling strategy: population based study
  publication-title: Sex Transm Infect
– volume: 5
  start-page: 433
  year: 1999
  article-title: Chlamydia trachomatis: impact on human reproduction
  publication-title: Hum Reprod Update
– volume: 358
  start-page: 1851
  year: 2001
  article-title: Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection
  publication-title: Lancet
– volume: 185
  start-page: 252
  year: 2002
  article-title: Population-based strategies for outreach screening of urogenital Chlamydia trachomatis infections: a randomised, controlled trial
  publication-title: J Infect Dis
– volume: 36
  start-page: 522
  year: 2009
  article-title: The English National Chlamydia Screening Programme: Variations in Positivity in 2007/2008
  publication-title: Sex Trans Dis
– volume: 36
  start-page: 577
  year: 2009
  article-title: Can E-Technology Through the Internet be Used as a New Tool to Address the Chlamydia trachomatis Epidemic by Home Sampling and Vaginal Swabs?
  publication-title: Sex Trans Dis
– volume: 16
  start-page: 397
  year: 1997
  article-title: Estimating means and percentages in a complex sampling survey: application to a French national survey on sexual behaviour (ACSF). analyse des comportements sexuels en France
  publication-title: Stat Med
– volume: 24
  start-page: 1185
  year: 2010
  article-title: CSF Group. Changes in sexual behaviours: from secular trends to public health policies
  publication-title: AIDS
– volume: 34
  start-page: 421
  year: 2007
  article-title: Home-based self-sampling and self-testing for sexually transmitted infections: acceptable and feasible alternatives to provider-based screening in low-income women in Sao Paulo, Brazil
  publication-title: Sex Trans Dis
– volume: 147
  start-page: 89
  year: 2007
  article-title: Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002
  publication-title: Ann Intern Med
– volume: 334
  start-page: 725
  year: 2007
  article-title: Screening programmes for chlamydial infection: when will we ever learn?
  publication-title: BMJ
– volume: 79
  start-page: 313
  year: 2003
  article-title: Chlamydial infection: an accurate model for opportunistic screening in general practice
  publication-title: Sex Transm Infect
– volume: 33
  start-page: 940
  year: 2005
  article-title: Coverage and uptake of systematic postal screening for genital Chlamydia trachomatis and prevalence of infection in the United Kingdom general population: cross sectional study
  publication-title: BMJ
– volume: 80
  start-page: 121
  year: 2004
  article-title: Prevalence of genital Chlamydia trachomatis infection in the general population of Slovenia: serious gaps in control
  publication-title: Sex Transm Infect
SSID ssj0006759
Score 2.2596636
Snippet BackgroundFew studies have estimated Chlamydia trachomatis (CT) prevalence in the general population, most prevalence studies being based on people already...
Background Few studies have estimated Chlamydia trachomatis (CT) prevalence in the general population, most prevalence studies being based on people already...
Few studies have estimated Chlamydia trachomatis (CT) prevalence in the general population, most prevalence studies being based on people already attending...
Objectives: Few studies have estimated Chlamydia trachomatis (CT) prevalence in the general population, most prevalence studies being based on people already...
SourceID hal
proquest
pubmed
pascalfrancis
crossref
istex
bmj
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 263
SubjectTerms Adolescent
Adult
Aged
Asymptomatic
Bacterial diseases
Bacterial diseases of the genital system
Biological and medical sciences
Chlamydia
Chlamydia Infections - epidemiology
Chlamydia trachomatis
Condoms - utilization
Education
Epidemiology. Vaccinations
Feasibility Studies
Female
France - epidemiology
Gender
General aspects
Health Surveys
Home Care Services
Human bacterial diseases
Human infectious diseases. Experimental studies and models
Humans
Infections
Infectious diseases
Male
Mass Screening - methods
Medical sciences
Middle Aged
Participation
Population Surveillance
population-based
Prevalence
Questionnaires
Risk Factors
Sexual behavior
Sexual Partners
Unsafe Sex - statistics & numerical data
Urine
Women
Young Adult
Title Prevalence of Chlamydia trachomatis: results from the first national population-based survey in France
URI https://sti.bmj.com/content/86/4/263.full
https://api.istex.fr/ark:/67375/NVC-DZFFK8X4-6/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/20660590
https://www.proquest.com/docview/1781726628
https://www.proquest.com/docview/749023593
https://hal.science/hal-00557458
Volume 86
WOSCitedRecordID wos000280363600005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1472-3263
  dateEnd: 20250506
  omitProxy: false
  ssIdentifier: ssj0006759
  issn: 1368-4973
  databaseCode: 7X7
  dateStart: 19980201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central Database Suite (ProQuest)
  customDbUrl:
  eissn: 1472-3263
  dateEnd: 20250506
  omitProxy: false
  ssIdentifier: ssj0006759
  issn: 1368-4973
  databaseCode: BENPR
  dateStart: 19980201
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 1472-3263
  dateEnd: 20250506
  omitProxy: false
  ssIdentifier: ssj0006759
  issn: 1368-4973
  databaseCode: M2P
  dateStart: 19980201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwELboihAv_Bg_FhiVBQjxkq2J49jhBY2yahJbVSFAFS-W7dja2GhL01bsv-cucTPtYfDAS6WmsaXmvpy_s-_uI-R1IUrpjO3HmlkeZ8yxWEpmYu18phOXlqax9LEYjeRkUozDhlsV0io3PrF21OXM4h75fiIkrLV5nsr3818xqkbh6WqQ0OiQLjCbBFO6TtJx64mBDBdN3ZVEJTUWWvvA9314f0KzSgaMPYWVxfz8cW1t6pxiZmQXH_ZvzJjUFTw036hd3ExH62VpeP9__9ADci8QUnrQIOghueWm26jlHPI-tsmdk3D8_oh4bPik6zIlOvN0cApwugSA0eWiFl3BSol3FAL41cWyoli5QoFfUn8GFJNuth3pvNUMi3ENLWm1WqzdJT2b0lrmwz0mX4eHXwZHcRBqiA3vp8vYA0eT2JdGWp8b7jKXGMP61nPrC5tInTvuUy-1T0telhCSSp8zoaVJXOaFZU_I1nQ2dTuEwgVuPE8FFyYDdqYzm5lS2n6hIRQyIiKvwFBq3rTiUHUIw3IF5kRBzUI15ozI3saQyoZe5yi5cXHzgLftgH_O_RKQ0d6F7bmPDo4VXqsbmmVcrpOIvKmB096mF-eYQie4Gn0bqI_fh8NPcpKpPCK9a8hqB0BoCKFxLiOyu4GPCu6lUlfYiQhtfwbHgKc9eupmq0qJrMBeRgWLyNMGoVdzA8_EouNnf5_7Obnb5EpguuMu2VouVu4FuW3XAKZFj3TERNSfske6Hw5H48-9-vX7A7qcMbE
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB71gYALj_IylLLiJS6m8XuNhFCVEqVqGvVQqojLsrveVQslCXYSyJ_iNzLjV9VD4dQDRz92JXu_mZ2xZ74P4GWaZNwo3XFloCM3DEzgch4oVxobSs_4mapWepAMh3w0Sg9X4HfTC0NllY1PLB11NtH0jXzbSzjutXHs8w_THy6pRtHf1UZCo4LFvln-xJSteL-3i-v7yvd7H4-6fbdWFXBV1PFnrsWAghOJCtc2VpEJjadU0NE20jbVHpexiaxvubR-FmUZ5k_cxkEiufJMaBMd4LyrsB4SsxiVCvqHrefH4Dut-rw4KbcFNZUQHm-jvdbkmAFmCD7uZOr71wt74eoJVWKu0-L-ogpNWeAi2Upd4_Lwt9wGe7f_txd4B27VATfbqSzkLqyY8QZpVdd1LRtw_aAuL7gHlgitZNmGxSaWdU_QXJZoQGyWl6Iy1AnyjuWmmJ_NCkadOQzjZ2ZPMYRmzWdVNm010VyKETJWzPOFWbLTMStlTMx9-HQlT_wA1saTsXkEDE9EykZ-EiUqxOhThjpUGdedVGKqpxIHXiAwxLSiGhFlihbEAuFDgqGpqODjwNsGOELXXO4kKXJ2-YA37YB_zv0ckdjeRfTj_Z2BoHMlYVsY8YXnwOsSqO1tMv9GJYJJJIbHXbH7udfb56NQxA5sXUByOwBTX0z9Y-7AZgNXUbvPQpxj1QHWXkbHR3-z5NhM5oVIwpS4mtLAgYeVRZzPjXE0NVU__vvcz-BG_-hgIAZ7w_0ncLOqC6HSzk1Ym-Vz8xSu6QUCK98qzZzBl6s2iz-2fo1w
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB61Caq48CgvQykrXuJiEnv9WCMhVJJGrRKiCgGKuCy76121UJJgJ4H8NX4ds35VPRROPXD0Y1ey95udb-yZ-QCeJnHKtFRdV1AVugHV1GWMSldoEwhP-6ksV3oUj8dsMkmONuB3XQtj0yrrPbHYqNOZst_IO17M0NdGkc86pkqLOOoP3sx_uFZByv5preU0SogM9fonhm_568M-rvUz3x_sf-gduJXCgCvDrr9wDZILZhuqMGUiGepAe1LSrjKhMonymIh0aHzDhPHTME0xlmImorFg0tOBiRXFeTehHSPJCFrQfrs_Pnrf-AGk4klZ9cWsjhutGgvhcQett2qVSTFe8NGvye9fz3nGzWObl9m2S_3L5muKHJfMlFobF5PhwikOrv_Pr_MGXKuoONkrbecmbOjptlWxrjJetmHrXZV4cAuMbXUligItMjOkd4yGtEbTIouskJuxNSKvSKbz5ekiJ7ZmhyCzJuYEyTWpP7iSeaOW5lr2kJJ8ma30mpxMSSFwom_Dx0t54jvQms6m-h4QPBFKE_pxGMsAeakIVCBTprqJwCBQxg48QZDwedmEhBfBG404QslKiSa8hJIDL2sQcVV1ebdiI6cXD3jRDPjn3I8Rlc1dtjH5wd6I23NFK7cgZCvPgecFaJvbRPbNJg_GIR9_6vH-58FgyCYBjxzYPYfqZgAGxWhOEXNgp4YurzbWnJ_h1gHSXMYt0f7nElM9W-Y8DhLbxSmhDtwtreNsbmTYttz6_t_nfgRbaA18dDgePoCrZcKIzfncgdYiW-qHcEWtEFfZbmXzBL5ctl38Aacrl4o
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+Chlamydia+trachomatis%3A+results+from+the+first+national+population-based+survey+in+France&rft.jtitle=Sexually+transmitted+infections&rft.au=Goulet%2C+V&rft.au=de+Barbeyrac%2C+B&rft.au=Raherison%2C+S&rft.au=Prudhomme%2C+M&rft.date=2010-08-01&rft.pub=BMJ+Publishing+Group+Ltd&rft.issn=1368-4973&rft.eissn=1472-3263&rft.volume=86&rft.issue=4&rft.spage=263&rft_id=info:doi/10.1136%2Fsti.2009.038752&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_NVC_DZFFK8X4_6
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1368-4973&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1368-4973&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1368-4973&client=summon